Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Ann Cardiol Angeiol (Paris) ; 67(5): 374-380, 2018 Nov.
Artigo em Francês | MEDLINE | ID: mdl-30301544

RESUMO

Since its first description in Japan in 1990, Takotsubo (stress) cardiomyopathy has gained worldwide recognition. The disease is characterized by transient systolic and diastolic left ventricular dysfunction with a variety of wall-motion abnormalities. She predominantly affects elderly women and she is often preceded by an emotional or physical trigger. In the acute phase, the clinical presentation, electrocardiographic findings and biomarker profiles are often similar to those of an acute coronary syndrome. Although, the cause of Takotsubo cardiomyopathy remains unknown, the role of the brain-heart axis in the pathogenesis of the disease has been described. The potential role of catecholamine excess in the pathogenesis of Takotsubo cardiomyopathy has been long debated, and as such beta-blockers have been proposed as a therapeutic strategy. Currently, the treatment is not codified and it adapts according to clinical symptomatology. It seems difficult to summarize all the factors to provoque the cardiomyopathy, we describe a case of Takotsubo after a pacemaker (PM) implantation and to give a recent progress on this heart disease.


Assuntos
Marca-Passo Artificial/efeitos adversos , Cardiomiopatia de Takotsubo/diagnóstico , Idoso de 80 Anos ou mais , Fibrilação Atrial/terapia , Eletrocardiografia , Feminino , Humanos , Fibrilação Ventricular/terapia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...